Because ZNF282 functions as a transcription co-activator of E2F1, which is a critical player in tumor progression, we investigated whether the prognostic effect of ZNF282 in ESCC was influenced by E2F1. This evidence concerns the gene E2F1 and esophageal squamous cell carcinoma.